Close Menu

NEW YORK (360Dx) – Quidel announced today it has received CE marking for a near-patient diagnostic assay for determining troponin I levels as an aid in diagnosing myocardial infarction.

The TriageTrue High Sensitivity Troponin I Test is a single-use fluorescence immunoassay that detects a subunit of the troponin complex released by heart muscle cells after a myocardial infarction. The test is run using whole blood or plasma specimens that have been anticoagulated with EDTA on the Quidel Triage Meter Pro instrument.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.